Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation THT Abstracts 2025

ECG-Based Deep Learning Algorithm for Risk Stratification of Left Ventricular Systolic Dysfunction: A Retrospective Single-Center Study

Presenter: Neil Keshvani

February 11, 2025

Presentation THT Abstracts 2025

Acute Hemodynamic Effects of VA-ECMO on Arterial Afterload in a Preclinical Model of Normal Left Ventricular Function After Exposure to Vasodilators

Presenter: Kay Everett

February 11, 2025

Presentation THT Abstracts 2025

Validation of Left Ventricular Ejection Time Measurement With CardioTag Wearable Patch Hardware

Presenter: Venu Ganti

February 11, 2025

Presentation THT Abstracts 2025

Use of Vericiguat in Durable Left Ventricular Assist Device Patients

February 11, 2025

Presentation THT Abstracts 2025

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

Presenter: Kanika Mody

February 11, 2025

Presentation THT Abstracts 2025

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Presenter: Kanika Mody

February 11, 2025

Presentation THT Abstracts 2025

Efficacy of Silverlon Silver Plated Dressing Pad in Reducing Left Ventricular Assist Device Driveline Infections When Compared to Chlorhexidine Impregnated Disc

Presenter: John DePietro

February 11, 2025

Presentation THT Abstracts 2025

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Presenter: Van-Khue Ton

February 11, 2025

Advertisement

ECG-Based Deep Learning Algorithm for Risk Stratification of Left Ventricular Systolic Dysfunction: A Retrospective Single-Center Study

Acute Hemodynamic Effects of VA-ECMO on Arterial Afterload in a Preclinical Model of Normal Left Ventricular Function After Exposure to Vasodilators

Validation of Left Ventricular Ejection Time Measurement With CardioTag Wearable Patch Hardware

Use of Vericiguat in Durable Left Ventricular Assist Device Patients

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Efficacy of Silverlon Silver Plated Dressing Pad in Reducing Left Ventricular Assist Device Driveline Infections When Compared to Chlorhexidine Impregnated Disc

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content